Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x100px

Person › Details

Jordan Zwick (Mirador Therapeutics Inc.)

Zwick, Jordan (Mirador Therapeutics 202403 CBO formerly InflaRx before Salix + Medtronic)

	Organisation	Mirador Therapeutics Inc.
	Former/major organisation	InflaRx N.V. (Nasdaq Global Select Market: IFRX)
	Group	InflaRx (Group)
	Product	IFX-1 (InflaRx)

Record changed: 2024-03-24

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Jordan Zwick

[1] InflaRx N.V.. (10/19/21). "Press Release: InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19". Jena....
[2] InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]